| Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... The Lancet 393 (10185), 2051-2058, 2019 | 1409 | 2019 |
| Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II … V Gondi, SL Pugh, WA Tome, C Caine, B Corn, A Kanner, H Rowley, ... Journal of Clinical Oncology 32 (34), 3810, 2014 | 1024 | 2014 |
| Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial W Roa, PMA Brasher, G Bauman, M Anthes, E Bruera, A Chan, B Fisher, ... Journal of clinical oncology 22 (9), 1583-1588, 2004 | 966 | 2004 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial DA Palma, R Olson, S Harrow, S Gaede, AV Louie, C Haasbeek, L Mulroy, ... Journal of Clinical Oncology 38 (25), 2830, 2020 | 678 | 2020 |
| Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer CN Catton, H Lukka, CS Gu, JM Martin, S Supiot, PWM Chung, ... Journal of Clinical Oncology 35 (17), 1884-1890, 2017 | 585 | 2017 |
| Supratentorial low-grade glioma in adults: an analysis of prognostic factors and timing of radiation C Leighton, B Fisher, G Bauman, S Depiero, L Stitt, D Macdonald, ... Journal of Clinical Oncology 15 (4), 1294-1301, 1997 | 444 | 1997 |
| Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis G Bauman, K Lote, D Larson, L Stalpers, C Leighton, B Fisher, W Wara, ... International Journal of Radiation Oncology* Biology* Physics 45 (4), 923-929, 1999 | 274 | 1999 |
| Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas GS Bauman, Y Ino, K Ueki, MC Zlatescu, BJ Fisher, DR Macdonald, L Stitt, ... International Journal of Radiation Oncology* Biology* Physics 48 (3), 825-830, 2000 | 266 | 2000 |
| 68Ga-labeled prostate-specific membrane antigen ligand positron emission tomography/computed tomography for prostate cancer: a systematic review and meta-analysis FE von Eyben, M Picchio, R von Eyben, H Rhee, G Bauman European urology focus 4 (5), 686-693, 2018 | 256 | 2018 |
| Prostate volume contouring: a 3D analysis of segmentation using 3DTRUS, CT, and MR WL Smith, C Lewis, G Bauman, G Rodrigues, D D’Souza, R Ash, D Ho, ... International Journal of Radiation Oncology* Biology* Physics 67 (4), 1238-1247, 2007 | 228 | 2007 |
| A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme GS Bauman, LE Gaspar, BJ Fisher, EC Halperin, DR Macdonald, ... International Journal of Radiation Oncology* Biology* Physics 29 (4), 835-839, 1994 | 207 | 1994 |
| Radiopharmaceuticals for the palliation of painful bone metastases—a systematic review G Bauman, M Charette, R Reid, J Sathya, TRGG of Cancer Radiotherapy and oncology 75 (3), 258. E1-258. E13, 2005 | 201 | 2005 |
| Tracking the dose distribution in radiation therapy by accounting for variable anatomy B Schaly, JA Kempe, GS Bauman, JJ Battista, J Van Dyk Physics in Medicine & Biology 49 (5), 791, 2004 | 195 | 2004 |
| Adaptive radiotherapy planning on decreasing gross tumor volumes as seen on megavoltage computed tomography images C Woodford, S Yartsev, AR Dar, G Bauman, J Van Dyk International Journal of Radiation Oncology* Biology* Physics 69 (4), 1316-1322, 2007 | 191 | 2007 |
| 18F-fluorocholine for prostate cancer imaging: a systematic review of the literature G Bauman, T Belhocine, M Kovacs, A Ward, M Beheshti, I Rachinsky Prostate cancer and prostatic diseases 15 (1), 45-55, 2012 | 166 | 2012 |
| Reirradiation of primary CNS tumors. GS Bauman, PK Sneed, WM Wara, LJ Stalpers, SM Chang, ... International journal of radiation oncology, biology, physics 36 (2), 433-441, 1996 | 158 | 1996 |
| Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial DA Palma, R Olson, S Harrow, RJM Correa, F Schneiders, CJA Haasbeek, ... BMC cancer 19 (1), 1-15, 2019 | 157 | 2019 |
| Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910 TM Pisansky, D Hunt, LG Gomella, MB Amin, AG Balogh, DM Chinn, ... Journal of Clinical Oncology 33 (4), 332, 2015 | 152 | 2015 |
| Intensity-modulated radiotherapy in the treatment of prostate cancer G Bauman, RB Rumble, J Chen, A Loblaw, P Warde, ... Clinical Oncology 24 (7), 461-473, 2012 | 143 | 2012 |
| Prostate histopathology: Learning tissue component histograms for cancer detection and classification L Gorelick, O Veksler, M Gaed, JA Gómez, M Moussa, G Bauman, ... IEEE transactions on medical imaging 32 (10), 1804-1818, 2013 | 131 | 2013 |
